Exact Mass: 335.246

Exact Mass Matches: 335.246

Found 26 metabolites which its exact mass value is equals to given mass value 335.246, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

   

Neovasipyridone C

Neovasipyridone C

C20H33NO3 (335.246)


   

3,7-dimethoxy-2-methyl-5-octanyl-5,6,7,8-tetrahydroquinoline-4(1H)-one|chamaedrone

3,7-dimethoxy-2-methyl-5-octanyl-5,6,7,8-tetrahydroquinoline-4(1H)-one|chamaedrone

C20H33NO3 (335.246)


   

Oxime-Mutilin

Oxime-Mutilin

C20H33NO3 (335.246)


   

N-(2E,9Z-hexadecadienoyl)-homoserine lactone

N-(2E,9Z-hexadecadienoyl)-homoserine lactone

C20H33NO3 (335.246)


   

1-NITRO-2-(TETRADECYLOXY)BENZENE

1-NITRO-2-(TETRADECYLOXY)BENZENE

C20H33NO3 (335.246)


   

Ganciclovir sodium

Ganciclovir sodium

C20H33NO3 (335.246)


   

oxeladin

oxeladin

C20H33NO3 (335.246)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents

   

2,6,8-Trimethyl-3-amino-9-benzyl-9-methoxynonanoic acid

2,6,8-Trimethyl-3-amino-9-benzyl-9-methoxynonanoic acid

C20H33NO3 (335.246)


   

N-linolenoylglycine

N-linolenoylglycine

C20H33NO3 (335.246)


   

NA-Dopamine 12:0

NA-Dopamine 12:0

C20H33NO3 (335.246)


   

NA-Gly 18:3(6Z,9Z,12Z)

NA-Gly 18:3(6Z,9Z,12Z)

C20H33NO3 (335.246)


   

NA-Gly 18:3(9Z,12Z,15Z)

NA-Gly 18:3(9Z,12Z,15Z)

C20H33NO3 (335.246)


   

(2s,3s,4as,5s,8ar)-2-methyl-5-[(1z,3e)-octa-1,3-dien-1-yl]-decahydroquinolin-3-yl 2-hydroxyacetate

(2s,3s,4as,5s,8ar)-2-methyl-5-[(1z,3e)-octa-1,3-dien-1-yl]-decahydroquinolin-3-yl 2-hydroxyacetate

C20H33NO3 (335.246)


   

3,7-dimethoxy-2-methyl-5-octyl-5,6,7,8-tetrahydro-1h-quinolin-4-one

3,7-dimethoxy-2-methyl-5-octyl-5,6,7,8-tetrahydro-1h-quinolin-4-one

C20H33NO3 (335.246)


   

3-hydroxy-3-methyl-2-[(2e)-4-methylhex-2-en-2-yl]-1-(2-methylpropyl)-5-propanoyl-2h-pyridin-4-one

3-hydroxy-3-methyl-2-[(2e)-4-methylhex-2-en-2-yl]-1-(2-methylpropyl)-5-propanoyl-2h-pyridin-4-one

C20H33NO3 (335.246)


   

(2s,3s,4as,5r,8ar)-2-methyl-5-[(1e,3e)-octa-1,3-dien-1-yl]-decahydroquinolin-3-yl 2-hydroxyacetate

(2s,3s,4as,5r,8ar)-2-methyl-5-[(1e,3e)-octa-1,3-dien-1-yl]-decahydroquinolin-3-yl 2-hydroxyacetate

C20H33NO3 (335.246)


   

(3e)-1-[(2e)-4-hydroxy-5-pentyl-5h-1,3-oxazol-2-ylidene]-4-methylundec-3-en-2-one

(3e)-1-[(2e)-4-hydroxy-5-pentyl-5h-1,3-oxazol-2-ylidene]-4-methylundec-3-en-2-one

C20H33NO3 (335.246)


   

(2r,3s)-3-hydroxy-3-methyl-2-[(2e,4s)-4-methylhex-2-en-2-yl]-1-(2-methylpropyl)-5-propanoyl-2h-pyridin-4-one

(2r,3s)-3-hydroxy-3-methyl-2-[(2e,4s)-4-methylhex-2-en-2-yl]-1-(2-methylpropyl)-5-propanoyl-2h-pyridin-4-one

C20H33NO3 (335.246)


   

n-[(4-hydroxy-3-methoxyphenyl)methyl]dodecanamide

n-[(4-hydroxy-3-methoxyphenyl)methyl]dodecanamide

C20H33NO3 (335.246)


   

(2s,3s,4as,5s,8ar)-2-methyl-5-[(1e,3e)-octa-1,3-dien-1-yl]-decahydroquinolin-3-yl 2-hydroxyacetate

(2s,3s,4as,5s,8ar)-2-methyl-5-[(1e,3e)-octa-1,3-dien-1-yl]-decahydroquinolin-3-yl 2-hydroxyacetate

C20H33NO3 (335.246)


   

(5r,7s)-3,7-dimethoxy-2-methyl-5-octyl-5,6,7,8-tetrahydro-1h-quinolin-4-one

(5r,7s)-3,7-dimethoxy-2-methyl-5-octyl-5,6,7,8-tetrahydro-1h-quinolin-4-one

C20H33NO3 (335.246)


   

2-methyl-5-(octa-1,3-dien-1-yl)-decahydroquinolin-3-yl 2-hydroxyacetate

2-methyl-5-(octa-1,3-dien-1-yl)-decahydroquinolin-3-yl 2-hydroxyacetate

C20H33NO3 (335.246)


   

(2r,3r)-3-hydroxy-3-methyl-2-[(2e,4r)-4-methylhex-2-en-2-yl]-1-(2-methylpropyl)-5-propanoyl-2h-pyridin-4-one

(2r,3r)-3-hydroxy-3-methyl-2-[(2e,4r)-4-methylhex-2-en-2-yl]-1-(2-methylpropyl)-5-propanoyl-2h-pyridin-4-one

C20H33NO3 (335.246)


   

3-hydroxy-3-methyl-2-(4-methylhex-2-en-2-yl)-1-(2-methylpropyl)-5-propanoyl-2h-pyridin-4-one

3-hydroxy-3-methyl-2-(4-methylhex-2-en-2-yl)-1-(2-methylpropyl)-5-propanoyl-2h-pyridin-4-one

C20H33NO3 (335.246)